Product Images Gabapentin

This is a clinical trial report showing the mean pain score for two groups over a 4-week period. One group received a placebo while the other group received a high dose of gabapentin. The baseline pain score is not provided.*

This appears to be a graph or chart related to a study on pain management. The chart includes four different treatment groups: placebo, 1800 mg/day gabapentin, 2400 mg/day gabapentin, and a titration period with increasing doses of gabapentin. The vertical axis likely represents the mean pain score, and the horizontal axis represents time in weeks. Without additional context, it is difficult to provide a more detailed description.*

The text provides a figure showing the proportion of responders in controlled PHN studies with different percentages ranging from 10% to 100%. The figure is accompanied by some text indicating the percentage of reduction in pain score experienced by patients as well as the results of some studies labelled as Study 1, Study 2, etc. The text also includes some drug names such as GBP 3600, GBP 1800 and GBP 2400. The meaning of these drug names is not clear from the given text. Therefore, it can be concluded that the text provides information about a study related to pain reduction but further information is needed to understand the context completely.*

This text seems to be a product description for ThansenTIN, a supplement containing 300mg of an unidentified substance. The product comes in a bottle of 160 capsules and has a product number of "5633-0". The first few characters "1mc, zotpe" do not provide useful information, and the last line "STOnE AT 810 7 Decaces ¢" is not recognizable.*

This appears to be a product label for "GharsenTIN" with a dosage of 480mg, contained in 90 capsules. The label also provides storage instructions to keep the product at -7 degrees Celsius.*